19 Early-Stage Venture Capital For Scientific Breakthroughs companies

We identify, fund, and actively build companies around humanity-improving breakthroughs originated at universities and institutions.

We invest in disruptive, world-changing ventures forged by ambitious founders and powered by compelling scientific breakthroughs.

We invest at the very earliest point of innovation, way before other venture capital funds!

Funding and commercialising exciting Deep-Tech solutions via Venture Co-Creation (VCC).

Mission BioCapital is a VC firm making pivotal early-stage investments in biotech companies.

Elm Street Ventures is a seed and early stage venture fund based in New Haven, Connecticut.

Level invests in outlier venture firms globally.

Early-stage funding for European life sciences companies.

Investing in scalable early-stage companies with exceptional defensibility.

Investing at the frontier of Research Innovation. Stoic is a venture firm investing in emerging science and engineering.

Atlas Venture invests in early-stage life sciences innovation. We partner with remarkable entrepreneurs to build breakthrough biotech companies.

Identifying true innovations and building ambitious companies.

Navam Capital is a venture capital firm focused on making early-stage investments in frontier technology ventures.

Invested in breaking ‍through paralysis.

We're a VC firm that champions entrepreneurs rewriting the future.

Fueling the growth and success of transformational companies from the University of Colorado.

We partner with founders commercializing scientific and technological breakthroughs in biological platforms and applied robotics.

Bold investment for overlooked founders and markets.

Investing in disruptive, early-stage biopharma companies across Europe.